India Pharma Serialization 2026: Schedule H2 QR Rules & CDSCO Compliance
India's 2026 amendment expands Schedule H2 QR-based drug traceability to vaccines, antimicrobials, and anti-cancer medicines. This guide explains CDSCO's requirements, the nine mandated data elements, phased 2027/2028 deadlines, and how batch-level QR authentication helps Indian pharma brands fight counterfeits.
Nov 7,2026













